APAC Melanoma Therapeutics Market Analysis


  • Type: Oncology area
  • Published : January 2022
  • Region: APAC
  • Country: Other
  • Report ID : 5001

  • Format: PPT, PDF

APAC Melanoma Therapeutics Market Analysis: Segmented by Cancer Stage, Cancer Type, Diagnosis, Treatment, Country- Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

SKU: 5001 Categories: ,

Report Description of the APAC Melanoma Therapeutics Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for APAC Melanoma Therapeutics Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the APAC Melanoma Therapeutics Market Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

APAC Melanoma Therapeutics Market Analysis Executive Summary

Melanoma is a very heterogeneous disease that includes coetaneous melanoma (CM), ocular melanoma (OM), mucosal melanoma (MM), melanoma of internal organs and, according to some classifications, soft tissue melanoma of the body (no bone and non-cartilaginous tissue). CM is by far the most common form, accounting for approximately 90-95% of all melanomas, and is one of the fastest growing cancers in the world.

Market Size and Key Findings

The APAC Melanoma Therapeutics Market Analysis size stood at around USD 0.91 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 16.40% during the forecast period.

The size of the Melanoma Therapeutics market in the Asia Pacific was worth USD 0.91 billion in 2020 and is estimated to be growing at a CAGR of 16.40% to reach USD xx billion by 2028.

Market Dynamics

Market Growth Drivers Analysis

The growth of the Asia-Pacific Melanoma Therapeutics market is mainly due to the rise in melanoma cases and growing awareness towards it. The APAC, Melanoma therapeutics market is expected to be driven by the factors such as the increase in the incidences of melanoma cases among the people, growing awareness, and rising demand for melanoma therapeutics across the region. In addition, melanoma is one of the latest-growing skin cancers in China, with high invasiveness and increased mortality rate among people is also expanding the market’s growth.

In addition, the growing geriatric population, technological advancements in the treatment for developing innovative and enhanced therapies for treating melanoma are expected to fuel the market growth. Moreover, the initiatives taken by the government for creating healthcare awareness among the people are expected to influence the market growth positively.

Market Restraints

The increase in the high costs of the treatment and therapies of melanoma disease with the lack of poor reimbursements policies are restraining the market growth of the melanoma therapeutics market. In addition, the lack of accessing facilities and well-developed healthcare facilities are also hindering the market’s growth. Furthermore, the strict government rules and regulations and stringent approval policies make the entry of the product more complex and hamper the market’s growth. Also, the lack of awareness among the people about the treatment and therapies available in the market limits the development of melanoma therapeutics in the market in the APAC region.

Competitive Landscape

Key Players

The  key  players  in  the  industry  are  profiled  providing  insights  on  their  financial  performance, market position and growth strategies. Comparative analysis on prime strategically activities of the    market    players    delineating    the    key    developments    like    mergers    &    acquisitions, collaborations  and  an  evaluation  of  the  competitive  environment  within  the  industry  are provided.  The  report  also  offers  a  broad  outlook  of  the  market  along  with  recommendations from industry experts on the opportunities for investment activity.

A few promising companies operating in the APAC melanoma therapeutics market profiled in this report are Bristol-Myers Squibb Co., Merck and Co., F. Hoffmann-La Roche, Amgen Inc., Celgene Corp, Daiichi Sankyo, and Pfizer Inc.

Products in Pipeline

Few of the key strategies adopted by leading players in the market are new product launches and fast track approvals. Recently, Bristol Myers Squibb (BMS) received an FDA clearance for supplemental Biologics License Application (sBLA) of Opdivo. In late 2014, the Food and Drug Administration (FDA) granted a fast track approval for a drug called Keytruda, developed by Merck & Co.

Notable Recent Deals

  • Bristol Myers Squibb (BMS), apposite product positioning of novel treatments in order to avoid cannibalization of marketed products would be a key challenge to sustain in the melanoma market. However, untapped geographical regions, which include some parts of Europe and the Asia Pacific with a high undiagnosed patient population, would provide lucrative growth opportunities.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

The Melanoma Dashboard was created in partnership with CDC’s Environmental Public Health Tracking Program to help communities address their unique melanoma prevention needs. It provides state- and county-level data on melanoma incidence, melanoma mortality, and UV irradiance. It also provides information about state policies regarding minors’ access to indoor tanning devices and sunscreen use at schools.

1. Report Description of the APAC Melanoma Therapeutics Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC Melanoma Therapeutics Market Analysis Executive Summary
2.1 APAC Melanoma Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC Melanoma Therapeutics Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Rise in melanoma cases
3.1.2 Growing awareness
3.1.3 Rising demand for melanoma therapeutics
3.2 Market Restraints Analysis
3.2.1 Increase in the high costs of the treatment
3.2.2 Poor reimbursements policies
3.2.3 Lack of accessing facilities
4. APAC Melanoma Therapeutics Market Segmentation
4.1 By Cancer Stage:
4.1.1 Stage 0
4.1.2 Stage I
4.1.3 Stage II
4.1.4 Stage III
4.1.5 Stage IV
4.2 By Cancer Type:
4.2.1 Nodular Melanoma
4.2.2 Acral Lentiginous Melanoma
4.2.3 Superficial spreading Melanoma
4.2.4 Lentigno Maligna Melanoma
4.2.5 Amelanotic Melanoma
4.2.6 Other
4.3 Diagnosis:
4.3.1 Ultrasound
4.3.2 Blood Tests
4.3.3 Dermatoscopy
4.3.4 Sentinel Lymph Node Biopsy
4.3.5 X-rays
4.3.6 CT /Scan
4.4 Treatment:
4.4.1 Early Melanoma
4.4.2 Targeted Therapy
4.4.3 Surgery
4.4.4 Chemotherapy
4.4.5 Radiotherapy
4.4.6 Immune Therapy
4.5 By Country:
4.5.1 India
4.5.2 China
4.5.3 Japan
4.5.4 South Korea
4.5.5 Australia
4.5.6 New Zealand
4.5.7 Thailand
4.5.8 Malaysia
4.5.9 Vietnam
4.5.10 Philippines
4.5.11 Indonesia
4.5.12 Singapore
4.5.13 Rest of APAC
5. APAC Melanoma Therapeutics Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Melanoma Therapeutics Market
6.4 Notable recent deals in Melanoma Therapeutics Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Daiichi Sankyo Company overview
Product & Services, Strategies & Financials
7.2 Bristol-Myers Squibb Company overview
Product & Services, Strategies & Financials
7.3 F. Hoffmann-La Roche, Ltd Company overview
Product & Services, Strategies & Financials
7.4 AB Science S.A. Company overview
Product & Services, Strategies & Financials
7.5 Pfizer, Inc. Company overview
Product & Services, Strategies & Financials
7.6 Eisai Co., Ltd. Company overview
Product & Services, Strategies & Financials
7.7 Amgen Inc. Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Melanoma Therapeutics market
9.2 Future Opportunities
10. Strategic Recommendations

APAC Melanoma Therapeutics Market Analysis Segmentation

By Cancer Stage:

On the basis of the cancer stage, the market is segmented into Stage 0, Stage I, Stage II, Stage III, and Stage IV.

By Cancer Type:

On the basis of cancer type, the market is segmented into superficial, nodular, lentigo maligna, acral lentiginous and amelanotic melanoma.

By Diagnosis:

Based on the diagnosis, the market is segmented into dermatoscopy, sentinel lymph node biopsy, X-rays, blood tests, CT scan, and ultrasound.

By Treatment:

Treatments for melanoma have been segmented into treatment for early stage melanoma (Excision and Mohs surgery) and treatment for advanced stage melanoma (chemotherapy, biological therapy, targeted therapy, radiotherapy, targeted therapy, immune therapy, lymphadenectomy).

By Country:

The Asia Pacific Melanoma Therapeutics market has geographically segmented into China, India, Japan, South Korea, and Australia. The Asia-Pacific Melanoma Therapeutics market is projected to grow at the highest CAGR during the forecast period due to reasons such as large population base and rising prevalence of melanoma. China is the largest market for Melanoma Therapeutics in this region followed by India.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements